Brookfield Asset Management's dividend hike signals strong growth potential. Read how BAM's growth may be driven by massive ...
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
Pilots who agree initiate a swooping turn that on final approach brings them northwest and low across the river — the path ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback